An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

Conditions: Pulmonary Sarcoidosis Interventions: Drug: XTMAB-16 Sponsors: Xentria, Inc. Not yet recruiting

Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials